Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Americas Gold & Silver (USAS) Cash & Equivalents (2016 - 2025)

Americas Gold & Silver has reported Cash & Equivalents over the past 11 years, most recently at $129.8 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 548.85% to $129.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $129.8 million through Dec 2025, up 548.85% year-over-year, with the annual reading at $129.8 million for FY2025, 548.85% up from the prior year.
  • Cash & Equivalents was $129.8 million for Q4 2025 at Americas Gold & Silver, up from $20.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $129.8 million in Q4 2025 and troughed at $890000.0 in Q3 2023.
  • The 5-year median for Cash & Equivalents is $3.1 million (2021), against an average of $14.4 million.
  • Year-over-year, Cash & Equivalents plummeted 93.36% in 2021 and then skyrocketed 2892.87% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $2.9 million in 2021, then tumbled by 32.28% to $2.0 million in 2022, then grew by 4.94% to $2.1 million in 2023, then surged by 870.5% to $20.0 million in 2024, then skyrocketed by 548.85% to $129.8 million in 2025.
  • Per Business Quant, the three most recent readings for USAS's Cash & Equivalents are $129.8 million (Q4 2025), $20.0 million (Q3 2025), and $61.7 million (Q2 2025).